Clinical Trial Update: Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 clinical trial evaluating a topical combination of calcipotriene and 5-fluorouracil for actinic keratosis in organ transplant rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Calcipotriene (calcipotriene)

Snippet

Sponsor: University of Arizona | Conditions: Actinic Keratosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING